Intracellular iron reportedly mediates many forms of tissue injury, including ischemic and myohemoglobinuric acute renal failure. This action may be explained by the ability of iron to catalyze the formation of the highly toxic hydroxyl radical (.OH) from H202 via the Fenton/Haber-Weiss reactions. To assess whether renal tubular myoglobin/iron loading, induced by a physiological mechanism (endocytosis), alters its susceptibility to 02 deprivation/reoxygenation-and H202-mediated injury, rats were infused with myoglobin or its vehicle (5% dextrose, control rats), and after 2 hours, proximal tubular segments (PTSs) were isolated for study. This infusion caused substantial myoglobin endocytic uptake (:25 ,tg/mg PTS protein), and it doubled PTS catalytic iron content (assessed by bleomycin assay). Nevertheless, PTS viability (percent lactate dehydrogenase release) was minimally affected (4% to 6% increase), and an increased -OH burden (assessed by the salicylate trap method) did not appear to result. Deferoxamine addition, reported to protect against in vivo acute renal failure, paradoxically increased OH levels (:25%) in myoglobin-loaded, but not control, PTSs. Conversely, dimethylthiourea (an *OH scavenger) depressed -OH (by z=:80%) in all PTSs. Myoglobin/iron loading modestly increased PTS vulnerability to exogenous H202 addition (P<.001). However, tubular susceptibility to hypoxia (15 and 30 minutes)/ reoxygenation injury was not affected. OH levels appeared to fall in response to both forms of injury, suggesting decreased -OH production and/or OH scavenging. To assess whether myoglobin decreases -OH levels in the presence of Fenton reactants, myoglobin and six other test proteins were incubated with Fe2+/H202. Myoglobin decreased *OH levels by =70%, a significantly greater decrement than was observed with the other proteins tested. Conclusions are as follows: (1) Myoglobin loading increases PTS catalytic iron content, predisposing to H202-mediated injury. (2) Myoglobin and deferoxamine can exert antioxidant and pro-oxidant effects, respectively. (3) PTS myoglobin loading does not worsen hypoxia/ reoxygenation injury, suggesting that myoglobinuria does not exacerbate in vivo ischemic acute renal failure by a direct proximal tubular cell effect. (Circ Res. 1993;73:926-934.) 
Despite these considerations, problems inherent in experiments in vivo (such as those above) make it difficult to conclude that proximal tubular cell iron, either in normal or excess concentrations, participates in either heme protein or ischemic ARF by directly altering tubular integrity. For example, FeCI3-EDTA, heme protein, and antioxidant effects on the kidney could be mediated primarily by hemodynamic or intraluminal influences rather than by directly influencing proximal tubular cell events. In addition, there is no experimental proof that intravenous Fe-EDTA or heme protein infusion actually increases intracellular proximal tubular free iron content. Finally, even if intracellular free iron loading were to occur under these conditions, whether the iron exists in a molecular form or at a subcellular location, which permits it to catalyze critical free radical reactions, is open to question.
Given these uncertainties as to the influence of iron on experimental ischemic and myohemoglobinuric ARF, this laboratory recently assessed the direct effect of catalytic (non-protein bound) iron on in vitro proximal tubular cell responsiveness to 02 deprivation/reoxygenation injury. 15 To this end, isolated rat proximal tubular segments (PTSs) were subjected to hypoxia/reoxygenation injury, either in the presence or absence of 2 mmol/L FeSO4 or FeCl3 added directly to the PTS suspension. 15 Although both iron salts caused marked PTS lipid peroxidation, each paradoxically mitigated hypoxic cell killing. Based on these findings, the generally held view that catalytic iron directly potentiates 02 deprivation/reoxygenation injury seems open to question.
Two potentially important facts need to be considered when interpreting the experiments described above. 15 First, the iron concentration used (2 mmol/L) far exceeded a physiologically relevant range (nanomolar to micromolar). Thus, it is possible that iron could have exerted a number of nonspecific pharmacological influences that overrode adverse free radical effects. Second, despite the massive extracellular iron additions, there was no proof that the iron reached critical intracellular locations. Of note, *OH is highly reactive, causing injury at the site of its production. Thus, the failure of exogenous iron to worsen in vitro hypoxia/ reoxygenation injury could have been due to its inability to reach physiologically relevant intracellular targets.
Given these uncertainties and in light of the widespread interest in the role of iron in cell injury, in general, and in ischemic and myohemoglobinuric ARF, in particular, the present study was undertaken to address the following specific questions: (1) Does myoglobinuria actually produce proximal tubular cell free iron loading, and if so, to what degree? (2) If proximal tubular free iron loading does result, is it in a form that permits it to catalyze critical free radical-based (eg, the Fenton/Haber-Weiss) reactions? (3) If myoglobin-liberated iron is, in fact, "catalytic," does its presence cause a potention of 02 deprivation/reoxygenation injury, as previously suggested?1"6'8 (4) Since DFO and -OH scavengers are reported to mitigate in vivo myohemoglobinuric ARF, do these agents actually decrease -OH concentrations within myoglobin-laden proximal tubular cells, supporting the concept that this is the reason for their protective effects? To address these issues, rat proximal tubules were myoglobin-loaded in vivo. After the tubules were isolated for in vitro study, *OH levels and cell viability were assessed in response to oxygenation and hypoxia/reoxygenation and during exogenous H202 addition. The results of these experiments form the basis of this report.
Materials and Methods In Vivo Myoglobin Loading and PTS Isolation
Male Sprague Dawley rats (weight, 175 to 300 g; Charles River Laboratories, Wilmington, Mass) were anesthetized with pentobarbital (30 to 40 mg/kg IP), and a PE-50 jugular venous catheter was inserted. Myoglobin loading of renal tubular cells was induced by infusing 50 mg purified horse skeletal muscle myoglobin of body weight at a constant rate over 2 hours (30 mg myoglobin per milliliter of 5% dextrose/water). Infusion of this myoglobin preparation (z80% ferrimyoglobin; iron content, 0.3%; >97% pure) in this, or lesser, amounts has previously been shown by this laboratory to markedly potentiate superimposed ischemic tubular necrosis and the severity of filtration failure without altering blood pressure or renal blood flow.13"4 On the basis of these findings, this preparation was selected for use in this investigation. Controls for these myoglobintreated rats consisted of rats infused with an equal volume of 5% dextrose/water (the myoglobin vehicle) over a 2-hour period. At the end of the infusions, the kidneys were resected through a midline abdominal incision, and they were immediately placed in ice-cold buffer ( 02-5% C02). Then PTSs were isolated, essentially as previously described (Reference 16; no DFO was used in the isolation process). In brief, the renal cortexes were dissected on a cooled surface, minced, and placed in 5 mL of buffer identical to that above except for 2.5 mmol/L CaCI2 and 1.2 mmol/L phosphate concentrations plus the addition of 25 mmol/L mannitol, 2.5 mg/mL fatty acid-free bovine serum albumin, 5 mmol/L glucose, 4 mmol/L sodium lactate, 1 mmol/L alanine, 10 mmol/L sodium butyrate, and 1.5 mg/mL collagenase D (Boehringer-Mannheim, Indianapolis, Ind). The final buffer pH, before collagenase addition, was adjusted to 6.5 by 1N HCI addition. The tissues were digested at 36°C in a rotating water bath for approximately 30 minutes, the flask was opened, 30 mL of ice cold buffer A was added, and then the digested tissue was passed through a stainless-steel sieve and centrifuged. The pellet was washed in 30 mL of fresh buffer A and then in 10 mL of buffer A containing 5% bovine serum albumin. The final pellet was added to 31% Percoll (in buffer A) and centrifuged (2000g for 10 minutes, 4°C), with viable PTSs being recovered at the bottom of the tube. 16 This material was washed twice in ice-cold buffer A to remove the Percoll, and the final pellet was suspended in an incubation medium consisting of (mmol/L) NaCl, 100; KCI, 2.1; NaHCO3, 25 To ascertain whether myoglobin infusion results in increased PTS-free iron content, the continuously oxygenated PTS aliquot from each of the above PTS preparations was assayed for catalytic iron by the bleomycin assay of Gutteridge and Hou,20 as previously described. 17 In brief, this assay is based on the principles that (1) bleomycin complexes non-protein-bound iron, (2) this complex can be quantified by its ability to induce oxidant DNA damage, and (3) this damage directly correlates with the initial free iron concentration. Corresponding PTS myoglobin concentrations were assessed by Drabkin's test (Sigma), using myoglobin as the standard.
Assessment of PTS OH Levels in the Presence and Absence of Myoglobin Loading
The following experiments were undertaken to ascertain whether (1) myoglobin-loaded PTSs generate excess OH, (2) DFO alters its production, and (3) DMTU, reported to protect against ischemic and myohemoglobinuric ARF,29 functions as an effective intracellular OH scavenger. Five separate myoglobin-loaded and five control PTS preparations were each divided into three aliquots: (1) continuous oxygenation for 75 minutes, (2) continuous oxygenation in the presence of 2 mmol/L DFO, and (3) continuous oxygenation in the presence of 10 mmol/L DMTU. Sodium salicylate, a stable OH trap, was added to each aliquot (2 mmol/L) at the start of the incubations. After 75 minutes, percent LDH release was determined, and then sample aliquots were lysed and analyzed for hydroxylated salicylate byproducts (2,3-and 2,5-dihydroxybenzoic acid [2,3-and 2,5 -DHBA, respectively]) by high-performance liquid chromatography using electrochemical detection. 21, 22 As previously reported by this laboratory and others, the degree of 2,3 -and 2,5 -DHBA production is an index of OH generation and concentrations.17,2'-28
The following experiment assessed whether myoglobin-loaded PTSs generate excess OH either during addition. Five PTS preparations, made from myoglobininfused rats, were each divided into three aliquots: (1) continuous oxygenation for 45 minutes, (2) To make certain that myoglobin infusion had induced tubular cell lysosomal myoglobin uptake, renal cortex from a typical myoglobin-infused rat was examined by light and transmission electron microscopy.
Results

Effects of Myoglobin Infusion on Renal Myoglobin and Catalytic Iron Accumulation
After completing 2 hours of myoglobin infusion, the kidneys were deeply pigmented with additional areas of punctate myoglobin accumulation observable on the cortical surfaces (Fig 1) Fig 6) . However, DFO addition to myoglobin-loaded PTSs paradox-A. 15 ically increased both 2,5-and 2,3-DHBA concentrations (by 25% and 32%, respectively, over values observed in the coincubated myoglobin-loaded/non-DFO-exposed PTSs; P<.02). Total DHBA concentrations for these myoglobin-loaded PTSs with and without DFO addition were 1.43±0.10 and 1.17+0.11 nmol/100 LDH units, respectively (P<.02). However, even with this DFO-driven DHBA increment, the DHBA levels still did not exceed those observed in the normal PTSs. PTSs incubated with DMTU. Addition of DMTU, an 0OH scavenger, caused marked suppression of both 2,5 -and 2,3-DHBA production by both the control and myoglobin-loaded PTSs (Fig 6) . The degree of suppression was greater for 2,5-DHBA than for 2,3-DHBA (85±1% versus 59 +5%, respectively; P<.001), confirming that in PTSs 2,5-DHBA is at least comparable to 2,3-DHBA as a marker of -OH-driven oxidant stress. '7 Overall statistical analysis ofDHBA production in myoglobin-loaded versus control PTSs during oxygenation. As depicted in Fig 6, comparisons of 2 Fe2/H202/ascorbate, in the absence of protein addition, caused marked 2,5-and 2,3-DHBA generation (from essentially zero DHBA to a total of 23±2 nmol/ mL; z60%/40%, 2,5-/2,3-DHBA, respectively). Myoglobin suppressed this DHBA production (by -70%), far more than any other test protein (Fig 8) . Hemocyanin stimulated DHBA production (from 23±2 to 44±4 nmol/mL) despite the fact that in the absence of Fe21 /H202/ascorbate it caused virtually no DHBA generation (-1 nmol/mL).
Discussion
Recently, there has been substantial interest in the role of heme protein-derived intracellular free iron as a promoter of oxidant cell stress, in general, and as a mediator of ischemic/reperfusion injury, in particular. Past in vivo and in vitro studies designed to address these issues have been hindered because in vivo experiments rarely provide information that can be directly extrapolated to primary cellular events and because in vitro studies of iron toxicity, which manipulate iron concentrations by exogenous iron addition or iron chelator therapy, are open to question since these interventions may fail to achieve the desired results at critical intracellular locations. Thus, the role of iron in the evolution of ischemic and heme protein-induced tubular necrosis has remained ill defined. Because of this, the present study was undertaken to directly assess whether heme protein loading of proximal tubules increases their catalytic iron content, whether this change predisposes to hypoxia/reoxygenation-and H202-induced cell injury, and if so, whether an increased -OH burden is responsible.
Because exogenous myoglobin or free iron addition to PTS suspensions does not ensure that intracellular targets are exposed, rats in the present study were subjected to intravenous myoglobin infusion for 2 hours, and then their proximal tubules were isolated for investigation. As shown in Fig 1, myoglobin infusion caused marked, and generalized, renal cortical myoglobin accumulation, and electron microscopy (Fig 2) confirmed that proximal tubular myoglobin incorporation within the endocytic-lysosomal system had occurred. Additional evidence for substantial PTS myoglobin loading included the following: a heme protein increment of 25 gg/mg PTS total protein; PTS, after exhaustive washings, visibly stained with heme pigment; and bleomycin analysis indicating an approximate doubling of "catalytic" free iron content. This latter observation is particularly important since it documents, for the first time, that a consequence of proximal tubular heme protein loading is increased intracellular catalytic iron activity. It is noteworthy that the free iron increment (3.5 nmol per milligram PTS protein) approximated, or was greater than, the amount of myoglobin uptake (;1.5 nmol per milligram PTS protein). This suggests that (1) catalytic iron is very rapidly liberated from myoglobin, once achieving an intracellular location; (2) proximal tubular heme protein overload causes sublethal cell injury, which secondarily releases iron from normal intracellular iron binding proteins29; or (3) circulating and/or intraluminal catalytic iron, which has previously been demonstrated in myohemoglobinuric states,17 is extracted by proximal tubules, thereby causing, or contributing to, the cell catalytic iron increment.
To ascertain whether myoglobin, and hence catalytic iron loading, does, in fact, directly impact on proximal tubular cell susceptibility to 02 deprivation/reoxygenation injury, PTSs, harvested from control and myoglobin-infused rats, were subjected to either mild (15-minute) or moderately severe (30-minute) hypoxic insults, and cell injury was assessed (LDH release) on completion of the hypoxic and reoxygenation periods.
As depicted in Fig 4, Because in vivo myohemoglobinuric ARF is reportedly associated with increased renal H202 production10 and because myoglobin infusion enhanced the PTS catalytic iron content, the next goal of the present study was to assess whether this increased iron burden predisposed PTSs to H202-mediated injury. Such a result would be predicted, since it has been well established that H202 cytotoxicity is free iron dependent (see References 17 through 19) . Thus, control and myoglobin-loaded PTSs were subjected to exogenous H202 addition, and as demonstrated in Fig 5, form.'7 However, whether DFO could exert this "prooxidant" effect at an intracellular location was not defined. The present results suggest that this is indeed the case since DFO addition significantly increased both 2,5-and 2,3-DHBA production in myoglobin-loaded, but not in control, PTSs. This raises the very real possibility that the cytoprotective influence of DFO on in vivo models of ARF8,9,17 may be expressed despite its potential pro-oxidant effect.
The fact that H202 addition to myoglobin-loaded PTSs markedly decreased DHBA generation raises two intriguing issues: (1) What, then, is the mechanism by which myoglobin loading predisposes to H202 toxicity? (2) What is the explanation for the apparent decrease in -OH concentrations? In regard to the first issue, it is quite possible that H202, which characteristically releases iron from intracellular binding proteins," causes marked iron liberation within myoglobin-laden PTSs.
Since H202 toxicity is catalytic iron dependent,17-'9 an excess iron burden might explain an increase in cell death. In regard to the second issue, the possibility was considered that myoglobin might suppress *OH levels in the presence of iron/H202. Thus, the effect of myoglobin addition on DHBA production, induced by FeSO4/ H202, was assessed. As depicted in Fig 8, 
